SEC Filing Details
Document Details
Form
Filing Date
March 11, 2026
Document Date
March 09, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
Collins Helen Louise